C. Balch

Lymphokine-activated killer cell activity Characteristics of effector cells and their progenitors in blood and spleen.

J. Ritz, L. Lanier, J. Phillips, 1987, Immunology today.

Study of Tumor-Infiltrating Lymphocytes for Adoptive Therapy of Renal Cell Carcinoma (RCC) and Metastatic Melanoma: Sequential Proliferation of Cytotoxic Natural Killer and Noncytotoxic T Cells in RCC

A. V. von Eschenbach, S. Legha, D. Parkinson, 1991, Journal of immunotherapy : official journal of the Society for Biological Therapy.

Characterization of a Subset of Human Natural Killer Cells That Express OKM1 But Lack HNK‐1 (Leu‐7) Antigens

T. Abo, R. Marolda, A. Tilden, 1984, Scandinavian journal of immunology.

Immunochemical Characterization of a Human B Lymphocyte Differentiation Antigen (p65)

C. Balch, S. Ferrone, E. Ades, 1980, Scandinavian journal of immunology.

VEP13-positive lymphocyte subpopulation Patients with a deficiency of natural killer cell activity lack the

T. Lebien, H. Ziegler-Heitbrock, R. Munker, 2013 .

Patients with a deficiency of natural killer cell activity lack the VEP13-positive lymphocyte subpopulation.

T. Lebien, H. Ziegler-Heitbrock, R. Munker, 1985, Blood.